Glycolytic inhibitor 2-deoxyglucose simultaneously targets cancer and endothelial cells to suppress neuroblastoma growth in mice

Neuroblastoma is characterized by a wide range of clinical manifestations and associated with poor prognosis when there is amplification of MYCN oncogene or high expression of Myc oncoproteins. In a previous in vitro study, we found that the glycolytic inhibitor 2-deoxyglucose (2DG) could suppress t...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chao-Cheng, Wang, Shuo-Yu, Lin, Li-Ling, Wang, Pei-Wen, Chen, Ting-Ya, Hsu, Wen-Ming, Lin, Tsu-Kung, Liou, Chia-Wei, Chuang, Jiin-Haur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610240/
https://www.ncbi.nlm.nih.gov/pubmed/26398947
http://dx.doi.org/10.1242/dmm.021667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610240/
https://www.ncbi.nlm.nih.gov/pubmed/26398947
http://dx.doi.org/10.1242/dmm.021667

Ejemplares similares